In the debate over the economic stimulus bill, it seemed like all politicians wanted to talk about was “shovel-ready” infrastructure projects. Congress’s love for roads and bridges notwithstanding, lawmakers did include a significant chunk of money for “shovel-ready” scientific research. The National Institute of Allergy and Infectious Diseases will get $1.12 billion from […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The Ebola Virus is Winning – This comprehensive analysis by J. Stephen Morrison of the Center for Strategic & International Studies explains how with unprecedented advantages […]